You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Interleukin-2
  • Placebo
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)

Recruiting
  • Sjögren's Syndrome
  • Beijing, Beijing, China
    Peking university people's hospital
Dec 2, 2022

HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

Terminated
Has Results
  • HIV Infection
  • Recombinant Interleukin-2
  • Cleveland, Ohio
    AIDS Clinical Trials Unit
Sep 1, 2022

Dermatomyositis Trial (Interleukin-2)

Not yet recruiting
  • Dermatomyositis
  • Interleukin-2
  • (no location specified)
Aug 8, 2022

Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)

Recruiting
  • Solid Tumor
  • TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
  • Aldesleukin
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 31, 2023

Purpura, Schoenlein-Henoch Trial in Changchun (IL-2)

Completed
  • Purpura, Schoenlein-Henoch
  • Changchun, Changchun/JiLin, China
    Sirui Yang
Aug 16, 2022

Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Proleukin 1.3 MG Injection
  • (no location specified)
Apr 6, 2023

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

Systemic Lupus Erythematosus Trial in Changchun (IL-2)

Completed
  • Systemic Lupus Erythematosus
  • Changchun, Changchun/Jilin, China
    Sirui Yang
Aug 16, 2022

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

Not yet recruiting
  • Lymphocytes
  • Tumor-Infiltrating
  • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
  • Saint Petersburg, Florida
  • +1 more
Sep 15, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

Acute Coronary Syndromes Trial in Cambridge (Interleukin-2 [IL-2], Placebo Dextrose 5% solution)

Recruiting
  • Acute Coronary Syndromes
  • Interleukin-2 [IL-2]
  • Placebo Dextrose 5% solution
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
May 31, 2022

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)

Suspended
  • Melanoma (Skin)
  • Melanoma in Situ
  • Aldesleukin
  • Saline
  • Halifax, Nova Scotia, Canada
    Queen Elizabeth II Health Sciences Centre
Jul 18, 2022

HIV-1 Infections Trial in Washington (HAART, T cells)

Completed
  • HIV-1 Infections
  • Washington, District of Columbia
    Walter Reed Army Medical Center
Aug 17, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023